Research roundup

Debbie Rigby rounds up the latest in research news An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks? Aspirin and anti-P2Y12 are widely prescribed in cardiovascular patients, often in combination with proton pump inhibitors (PPIs) to limit the risk of upper gastrointestinal bleedings. A large body of evidence describes